Company Filing History:
Years Active: 2017-2020
Title: The Innovative Contributions of Tao Shi
Introduction
Tao Shi is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of cancer treatment through his innovative research and development of aminopurine and pyrrolopyrimidine compounds. With a total of 2 patents, his work is paving the way for new therapeutic methods.
Latest Patents
Tao Shi's latest patents include "Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith." This patent outlines methods for treating or preventing cancer, including solid tumors and hematological cancers, by administering effective amounts of aminopurine compounds. Another notable patent is "Methods of treating a cancer using substituted pyrrolopyrimidine compounds, compositions thereof." This patent provides methods for treating or preventing cancer, particularly solid tumors and hematological cancers, through the administration of specific compounds.
Career Highlights
Tao Shi is currently employed at Signal Pharmaceuticals, Inc., where he continues to focus on developing innovative treatments for cancer. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
Tao has collaborated with notable colleagues, including John Frederick Boylan and David Mikolon, to further enhance the impact of his research and innovations.
Conclusion
Tao Shi's contributions to cancer treatment through his patented inventions demonstrate his dedication to medical innovation. His work not only reflects his expertise but also holds the potential to significantly improve therapeutic options for patients facing cancer.